Ichnos Sciences
Astria buys rights to Ichnosā eczema drug for $15M, joining crowded field of Amgen and Sanofi
Anika Sharma
Ichnos Sciences has secured a buyer for its OX40 eczema program, with Astria Therapeutics entering the scene by paying an ...
